- Home
- SSSS vs ALEC Comparison
SSSS vs ALEC Comparison
Compare SSSS & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.94
Company Overview
Basic Information| Metric | SSSS | ALEC |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.4M | 200.8M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SSSS | ALEC |
|---|---|---|
| Price | $9.75 | $1.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | ★ $10.13 | $3.33 |
| AVG Volume (30 Days) | 127.5K | ★ 1.0M |
| Earning Date | 03-10-2026 | 02-25-2026 |
| Dividend Yield | ★ 10.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.61 | N/A |
| Revenue | $2,354,933.00 | ★ $69,048,000.00 |
| Revenue This Year | $7,183.09 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.56 | ★ N/A |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $4.21 | $0.87 |
| 52 Week High | $10.34 | $3.40 |
Technical Indicators
Market Signals| Indicator | SSSS | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 57.83 | 66.88 |
| Support Level | $9.16 | $1.77 |
| Resistance Level | $9.90 | $2.00 |
| Average True Range (ATR) | 0.31 | 0.12 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 82.72 | 79.78 |
Price Performance
Historical Comparison SSSS
ALEC
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.